相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

了解lncRNA在铁灭中的作用的进展

Yating Wen¹, Wenbo Lei¹, Jie Zhang¹

¹Pathogenic Biology Institute, Hengyang Medical College, University of South China, Hengyang, Hunan, China.

|August 30, 2024

概括

长非编码RNAs (lncRNAs) 调节基因表达,并影响被编程的细胞死亡,包括ferroptosis. 这篇评论强调了 lncRNA 如何控制铁亡途径,影响细胞命运.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

长非编码RNAs (lncRNAs) 最初被认为是非功能转录,但现在被认为是关键的基因表达调节者.
铁亡是一种独特的编程细胞死亡形式,其特点是铁的积累和脂质过氧化,受到Nrf2,自和p53.3等途径的影响.
lncRNAs在调节各种细胞过程中发挥着至关重要的作用,包括编程细胞死亡.

研究的目的:

审查铁灭的调节机制.
强调 lncRNAs 在控制铁亡途径中的作用.
阐明 lncRNA 对细胞命运决定的影响.

主要方法:

文献综述和现有关于lncRNA和ferroptosis的研究的综合.
分析lncRNA的分子功能,包括诱效应,蛋白质支架和指导蛋白质相互作用.
检查lncRNA在ferroptosis中的表观遗传和遗传调节作用.

主要成果:

lncRNAs通过影响铁,脂质和抗氧化剂代谢,作为铁亡的关键调节者.
lncRNAs通过阻断基因表达,指导蛋白质功能和作为分子支架的机制来调节铁.
lncRNA调节会影响涉及铁亡的关键通路,包括Nrf2,自和p53.

结论:

lncRNAs是铁亡的重要调节者,通过多种分子机制影响细胞死亡途径.
了解lncRNA在铁亡中的作用,可以了解细胞命运的决定.
对lncRNA介导的铁灭调节的进一步研究可以揭示涉及细胞死亡的疾病的治疗点.

关键词:

自自是一种自的过程.铁化是铁化的一种.长长的非编码RNAs.Nrf2 路径的路径通过p53路径.

更多相关视频

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Formation of Muscle Fibers from Myoblasts

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...